1 Min Read
ZURICH (Reuters) - The Food and Drug Administration (FDA) has given clearance for Roche's new blood glucose monitor for hospital testing, the Swiss drugmaker said.
Roche, which earlier on Tuesday reported strong third quarter sales, said its ACCU-CHEK Inform II system allowed real-time wireless transfer of patient data between hospital medical staff and the laboratory.
The FDA clearance was the third for a diabetes product this year for Roche, the world leader in the blood glucose monitoring market with its Accu-Chek brand.
Reporting by Caroline Copley